Cytek Biosciences CTKB
NASDAQ CTKB
$5.87 +0.06 (+1.03%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cytek Biosciences (CTKB) Income from Non-Controlling Interests (2021 - 2022)

Updated

Cytek Biosciences' Income from Non-Controlling Interests came in at $189,000 for Q4 2022, up 626.9% from $26,000 a year earlier.

Analysis

Cytek Biosciences (CTKB) Income from Non-Controlling Interests (2021 - 2022) Analysis & Trends

For FY2022, Cytek Biosciences' Income from Non-Controlling Interests was -$92,000.

  • Going back by year, Income from Non-Controlling Interests was $26,000 in FY2021.
  • Business Quant data shows CTKB's Income from Non-Controlling Interests at -$40,000 (Q3 2022), $104,000 (Q2 2022) and $137,000 (Q1 2022) in the three quarters before Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn 5.00 Mn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn -
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn -
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn 5.10 Mn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn 9.00 Mn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn -
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn -2.00 Mn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn -500,000.00
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn -
10 Cytek Biosciences 763.00 Mn 439.27 Mn 28.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 189,000.00
Sep 30, 2022 -40,000.00
Jun 30, 2022 104,000.00
Mar 31, 2022 137,000.00
Dec 31, 2021 26,000.00
API Access

Cytek Biosciences Income from Non-Controlling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=CTKB&period=max&api_key=YOUR_API_KEY